FAM127B Activators encompass a diverse array of chemical compounds that potentially enhance the functional activity of FAM127B through various cellular signaling mechanisms. Forskolin, for instance, by increasing adenylyl cyclase activity, raises intracellular cAMP levels, which may lead to activation of protein kinase A (PKA) and subsequent enhancement of FAM127B functional pathways. IBMX also contributes to this cAMP-mediated signaling by inhibiting phosphodiesterases, thus sustaining elevated cAMP levels and potentially amplifying FAM127B-related pathways. Sphingosine-1-phosphate and PMA, through receptor-mediated and PKC activation respectively, could initiate a cascade of phosphorylation events that may include key substrates involved in FAM127B's activation. The calcium ionophore Ionomycin and the SERCA inhibitor Thapsigargin both serve to elevate intracellular calcium, a secondary messenger that could activate calcium-dependent protein kinases and phosphatases, potentially leading to enhanced FAM127B activity.
Additionally, the modulation of kinase activity by compounds such as Epigallocatechin gallate, LY294002, U0126, andSB203580, introduces an alternative mechanism for FAM127B activation. EGCG, by inhibiting certain kinases, might alleviate inhibitory control over FAM127B-involved pathways, whereas LY294002 and U0126 specifically target PI3K and MEK1/2, respectively, altering downstream signaling in a manner that could favor FAM127B activation. Furthermore, SB203580's inhibition of p38 MAPK may shift the signaling equilibrium towards pathways that enhance FAM127B function. The cAMP analog 8-Bromo-cAMP is poised to activate PKA, which can phosphorylate proteins within FAM127B's signaling network, potentially leading to its functional enhancement. Lastly, 2-APB, by modulating IP3 receptor function, affects calcium release and may influence FAM127B activity if it is regulated by calcium signaling. Collectively, these compounds represent a spectrum of biochemical interventions that, by influencing distinct yet interconnected signaling pathways, have the potential to augment the activity of FAM127B in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP. Increased intracellular cAMP could lead to activation of pathways involving FAM127B. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate interacts with its receptors to activate intracellular signaling cascades, potentially influencing the signaling pathways that modulate FAM127B activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may lead to the phosphorylation of proteins within pathways that involve FAM127B activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent pathways that could enhance FAM127B activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a cAMP analog, 8-Bromo-cAMP can activate PKA and subsequently pathways that could lead to the enhancement of FAM127B activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to inhibit certain protein kinases, which may relieve negative regulation on pathways associated with FAM127B, leading to its activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor which could alter signaling pathways downstream, including those in which FAM127B may play a role, leading to its functional enhancement. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor might indirectly enhance FAM127B activity by modulating related signaling pathways. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB affects calcium signaling by modulating IP3 receptors, which could increase the activity of FAM127B if it is regulated by calcium-dependent signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels and potentially promoting FAM127B activity through calcium-dependent pathways. | ||||||